Entrada Honored as a 2014 NEXT Award Winner

 

Nashville, TN, November 25, 2014 - Entrada, a leading provider of mobile productivity solutions for physicians and caregivers, was recently named by the Nashville Area Chamber of Commerce and the Nashville Entrepreneur Center as a 2014 NEXT Award winner. The NEXT Awards recognize innovative businesses in Nashville and Middle Tennessee with achievements such as demonstrating an “outstanding entrepreneurial spirit” and serving as a “mentor and advocate for other local entrepreneurs.” Entrada was honored as the winner of the Growth category within the technology industry at an awards dinner presented by Bank of America on Thursday, November 20th at the War Memorial Auditorium.

“We are truly honored to be named as a 2014 NEXT Award winner,” noted Chase Pattison, Chief Marketing Officer at Entrada. “There is such excitement about the growing entrepreneurial community in and around the Nashville area, especially within the healthcare technology sector, and we’re truly grateful to be recognized as a contributor to that momentum.”

Entrada provides a fast, easy way to document clinical information directly from a mobile device, enabling caregivers to stay productive before, during and after the transition to an electronic health record system. Entrada helps organizations optimize their EHR and clinical workflow, enhancing documentation quality and compliance while improving caregiver efficiency and satisfaction with their existing technology systems.

About Entrada

Entrada is a leading provider of integrated mobile solutions that improve healthcare efficiencies and outcomes. Entrada’s commitment is to protect physician and staff productivity for the next generation of patient care. For more information, please visit http://www.EntradaHealth.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.